Search results for "aDNA"

showing 10 items of 65 documents

Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating vir…

1998

Abstract Background/Aims: Seroconversion to anti-HBs or the loss of HBsAg is usually associated with complete elimination of the replicative hepatitis B virus. Usually in these patients hepatitis B virus DNA (HBV DNA) becomes undetectable. Routine controls of patients who underwent anti-HBs seroconversion by more sensitive tests showed that in some cases the virus persisted in the patient. Therefore the aim of our study was to evaluate if virus persistence could also be found in children with chronic hepatitis B after anti-HBs seroconversion. The virus pool should be characterized before and after seroconversion. Methods: Viral DNA was extracted from nine HBsAg negative or anti-HBs positive…

MaleHepatitis B virusHBsAgHepatitis B virus DNA polymeraseMolecular Sequence Datamedicine.disease_causeVirusOrthohepadnavirusmedicineHumansAmino Acid SequenceHepatitis B AntibodiesSeroconversionChildHepatitis B virusHepatitis B Surface AntigensHepatologybiologyInfantvirus diseasesHepatitis BHepatitis Bbiology.organism_classificationmedicine.diseaseVirologydigestive system diseasesHepadnaviridaeChild PreschoolChronic DiseaseDNA ViralImmunologyFemaleJournal of Hepatology
researchProduct

Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication.

2006

Objectives Interferons are known to inhibit the replication of hepatitis B viruses (HBV) in several animal models in vitro and in vivo as well in humans. The STAT-1 protein plays a central role in the biological activity of both type I and type II interferons. The lack of functional STAT-1 renders cells and organisms susceptible to bacterial and viral infectious agents. We analysed whether the overexpression of STAT-1 protein enhances the biological interferon response and whether it elicits antiviral acitivity against HBV in vitro. Methods To achieve an efficient STAT-1 overexpression in primary liver cells and hepatoma cells, we generated a recombinant, replication-deficient adenovirus ex…

Hepatitis B virusCarcinoma HepatocellularBlotting WesternGenetic Vectorsmedicine.disease_causeTransfectionVirus ReplicationVirusHepatitis B virus PRE betaAdenoviridaeOrthohepadnavirusInterferonmedicineTumor Cells CulturedAnimalsHumansCells CulturedHepatitis B virusHepatologybiologyLiver NeoplasmsGastroenterologyvirus diseasesHepatitis Bmedicine.diseasebiology.organism_classificationVirologyMolecular biologydigestive system diseasesIn vitroDucksSTAT1 Transcription FactorHepadnaviridaeGene Expression RegulationDNA ViralHepatocytesmedicine.drugEuropean journal of gastroenterologyhepatology
researchProduct

Biological standards for hepatitis B virus assays.

1992

Hepatitis B virusImmunoblottingBiologymedicine.disease_causePolymerase Chain ReactionVirusSerologylaw.inventionlawmedicineHumansHepatitis B AntibodiesPolymerase chain reactionHepatitis B virusHepatologyNucleic Acid HybridizationHepatitis BReference Standardsbiology.organism_classificationmedicine.diseaseHepatitis BVirologyIn vitroHepadnaviridaeDNA ViralViral diseaseJournal of hepatology
researchProduct

Duck Hepatitis B Virus Requires Cholesterol for Endosomal Escape during Virus Entry

2008

ABSTRACT The identity and functionality of biological membranes are determined by cooperative interaction between their lipid and protein constituents. Cholesterol is an important structural lipid that modulates fluidity of biological membranes favoring the formation of detergent-resistant microdomains. In the present study, we evaluated the functional role of cholesterol and lipid rafts for entry of hepatitis B viruses into hepatocytes. We show that the duck hepatitis B virus (DHBV) attaches predominantly to detergent-soluble domains on the plasma membrane. Cholesterol depletion from host membranes and thus disruption of rafts does not affect DHBV infection. In contrast, depletion of chole…

AvihepadnavirusbiologyvirusesImmunologyDuck hepatitis B virusBiological membraneEndosomesVirus Internalizationbiology.organism_classificationMicrobiologyVirologyVirusHepatitis B Virus DuckVirus-Cell InteractionsCholesterolViral envelopeHepadnaviridaeViral entryCell Line TumorVirologyInsect ScienceHepatocytesHumanslipids (amino acids peptides and proteins)Lipid raftJournal of Virology
researchProduct

Functional analysis of a rare HBV deletion mutant in chronically infected children.

2003

Liver damage caused by chronic hepatitis B virus (HBV) infection may be enhanced through the selection of deleted HBV preS mutants by intracellular accumulation of viral proteins and subsequent cell death. However, the prevalence and impact of such mutants on the clinical course of infection have not yet been studied in children. Serum samples from 60 children (mean age 9.8 y) were investigated by means of PCR and direct sequencing of the entire preS region. Only one patient (1.5%) was found with a mixed HBV population of a deletion spanning 183 nucleotides and wild-type sequences. This mutation alters the HBV large-surface protein and removes the small-surface promoter. To clarify the sign…

MaleHepatitis B virusAdolescentPopulationMutantmedicine.disease_causeEndoplasmic ReticulumPolymerase Chain ReactionVirusHepatitis B ChronicOrthohepadnavirusmedicineHumanseducationChildDNA PrimersSequence DeletionHepatitis B viruseducation.field_of_studyMutationExpression vectorbiologyBase SequenceInfantbiology.organism_classificationVirologyHepadnaviridaeChild PreschoolPediatrics Perinatology and Child HealthFemalePediatric research
researchProduct

Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.

1991

We have found a defective form of HBV2 in a HBsAg- and anti-HBe-positive patient with liver cancer. Viral deletions were identified in the preS coding region using PCR. The presence of deleted HBV forms was observed in serum, PBMC, and liver samples. After sequencing 12 clones were analyzed (subtype adr). In 9 out of 12 clones a 183-bp in-frame deletion was recorded in the preS1 region (2995 to 3177). Three out of 9 clones also yielded rearrangements of the preS2 N-terminal part. Four out of 9 showed numerous point mutations in the preS1 and preS2 sequence. In addition, 3 out of 12 clones, which did not show the 183-bp preS1 deletion were found to have small deletions and insertions in the …

AdultMaleHBsAgHepatitis B virusGenes ViralNeutrophilsMolecular Sequence Datamedicine.disease_causePolymerase Chain ReactionDefective virusVirusEpitopeVirologymedicineHumansProtein PrecursorsHepatitis B virusGene RearrangementHepatitis B Surface AntigensbiologyBase SequenceChromosome MappingDefective VirusesGene rearrangementbiology.organism_classificationHepatitis BVirologyHBcAgHepadnaviridaeLiverProtein BiosynthesisDNA ViralVirology
researchProduct

Semiquantitative assessment of pre-core stop-codon mutant and wildtype hepatitis B virus during the course of chronic hepatitis B using a new PCR-bas…

1996

In most patients with chronic hepatitis B positive for antibodies (anti-HBe) to HBe antigen (HBeAg), a pre-core mutant hepatitis B virus (HBV) with a point-mutation at nt. 1896 can be isolated. Clinical significance of the mutant virus in chronic hepatitis B is not proven yet, and screening of large numbers of sera during different clinical courses of numerous patients is necessary. We therefore aimed to develop a fast and reliable assay, that allows to discriminate wildtype from nt. 1896 G-->A mutant HBV and to determine the ratio of mutant and wildtype HBV in patients' sera. A mutation specific polymerase chain reaction (ms PCR) with new primers served to distinguish nt. 1896 G-->A mutant…

Hepatitis B virusMutantPopulationBiologymedicine.disease_causePolymerase Chain ReactionSensitivity and SpecificityViruslaw.inventionlawVirologymedicineHumansPoint MutationHepatitis B e AntigenseducationPolymerase chain reactionHepatitis B viruseducation.field_of_studyWild typevirus diseasesGeneral Medicinebiology.organism_classificationHepatitis BVirologydigestive system diseasesHBeAgHepadnaviridaeEvaluation Studies as TopicChronic DiseaseCodon TerminatorFollow-Up Studies
researchProduct

The affinities of monoclonal antibodies against core antigen of hepatitis B virus

1994

Four monoclonal antibodies generated against the recombinant core antigen of hepatitis B virus are investigated for antigen binding. All exhibit a similar affinity to polystyrene-sorbed antigen but only one of them interacts with native form of HBcAg (an assembled particle) in solution. The presence of 0.1% sodium dodecylsulphate is required for the binding of other three antibodies. The phenomenon can be interpreted as inaccessibility of the corresponding epitopes unless the multimeric antigen structure is disrupted. The core antigen coated on polystyrene is considered as a similar exposed structure.

medicine.drug_classAntibody AffinityBiologyAntibodies Viralmedicine.disease_causeMonoclonal antibodyEpitopeEpitopesMiceAntigenVirologymedicineAnimalsHepatitis B virusHybridomasT-cell receptorAntibodies MonoclonalSodium Dodecyl SulfateGeneral Medicinebiology.organism_classificationHepatitis B Core AntigensVirologyMolecular biologyRecombinant ProteinsHBcAgHepadnaviridaebiology.proteinAntibodyArchives of Virology
researchProduct

Relationship of pre-S encoded antigens in liver and clinical manifestations of chronic hepatitis B infection.

2008

Pre-S1 and pre-S2 encoded antigens of hepatitis B virus were localized in liver tissue using monoclonal antibodies. They were found to be exclusively expressed in the cytoplasm of liver cells. Cell bound pre-S1 encoded protein was often detected in patients with chronic liver disease and viremia. Only a small number of the HBsAg positive cells also contained pre-S1 antigen. There was no correlation with nuclear HBcAg. Livers of non-viremic HBsAg carriers contained many HBsAg expressing liver cells, that were frequently also positive for pre-S2 encoded protein but contained no detectable pre-S1 encoded protein at all. It remains open whether cell bound pre-S2 containing proteins of middle si…

HBsAgHepatitis B virusBiopsyRadioimmunoassayViremiaBiologyChronic liver diseaseImmunoenzyme Techniques03 medical and health sciencesLiver disease0302 clinical medicineAntigenmedicineHumans030304 developmental biologyHepatitis0303 health sciencesHepatitis B Surface AntigensHepatologyvirus diseasesmedicine.diseasebiology.organism_classificationHepatitis BVirology3. Good healthHBcAgHepadnaviridaeLiverImmunologyCarrier State030211 gastroenterology & hepatologyLiver
researchProduct

Development and characterization of a 293 cell line with regulatable expression of the hepatitis B virus large envelope protein

2004

During the life cycle of hepatitis B virus (HBV) the large L envelope protein plays a pivotal role that is related to its peculiar dual transmembrane topology. To study the complex structure and diverse functions of L under regulated conditions of production, a human 293 cell line stably expressing L under the control of the ecdysone-inducible promoter was generated. Cells demonstrated stringent dose- and time-dependent kinetics of induction with undetectable background expression in the absence of the inducer. Temporal control of L expression allowed to trace (i) its posttranslational reorientation resulting in the mixed topology; (ii) its spatial redistribution from the endoplasmic reticu…

Gene Expression Regulation ViralHepatitis B virusEcdysoneProtein ConformationEndoplasmic reticulumLiver cellCell MembraneCellGolgi ApparatusBiologyEndoplasmic Reticulummedicine.disease_causebiology.organism_classificationMolecular biologymedicine.anatomical_structureViral Envelope ProteinsHepadnaviridaeCell cultureVirologyMembrane topologymedicineHumansSecretionPromoter Regions GeneticCell Line TransformedJournal of Virological Methods
researchProduct